| RS2516811898 |
SCAF4
|
Health Risk |
Likely pathogenic |
Fliedner-Zweier syndrome, Fliedner-Zweier syndrome |
| RS2516812393 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS2516812694 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516814024 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516814422 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516815693 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516816762 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516817630 |
RUNX1
|
Health Risk |
Likely pathogenic |
Atypical chronic myeloid leukemia, BCR-ABL1 negative |
| RS2516818506 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516819138 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516819257 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516819502 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516820446 |
RUNX1
|
Health Risk |
Likely pathogenic |
RUNX1-related disorder, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516822206 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516824139 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516825380 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516825700 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516826656 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, language delay |
| RS2516829857 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516840293 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516840344 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516840809 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516841193 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516841458 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516850088 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2516850136 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS2516850368 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS2516851519 |
KCNB1
|
Health Risk |
Pathogenic |
— |
| RS2516851569 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2516851607 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2516851652 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2516851803 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2516851908 |
KCNB1
|
Health Risk |
Likely pathogenic |
KCNB1-related disorder, KCNB1-related disorder |
| RS2516851941 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS2516852313 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2516852481 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS2516852776 |
TMPRSS15
|
Health Risk |
Likely pathogenic |
— |
| RS2516853033 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516853102 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516853374 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516853620 |
HLCS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2516853656 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516853783 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516861844 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516861944 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2516867559 |
IFNAR1
|
Health Risk |
Pathogenic |
— |
| RS2516867646 |
IFNAR1
|
Health Risk |
Pathogenic |
— |
| RS2516867725 |
IFNAR1
|
Health Risk |
Pathogenic |
— |
| RS2516867828 |
IFNAR1
|
Health Risk |
Likely risk allele |
Susceptibility to severe COVID-19, Susceptibility to severe COVID-19 |
| RS2516869613 |
MRAP
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency 2, Glucocorticoid deficiency 2 |
| RS2516870215 |
NEDD4L
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2516871917 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516872094 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516872518 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516872544 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516872606 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516872951 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516873033 |
DSCAM
|
Health Risk |
Likely pathogenic |
DSCAM-related disorder, DSCAM-related disorder |
| RS2516873177 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516880373 |
IFNAR1
|
Health Risk |
Likely pathogenic |
— |
| RS2516880393 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516880424 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2516881002 |
IFNAR1
|
Health Risk |
Likely pathogenic |
— |
| RS2516885537 |
IFNAR1
|
Health Risk |
Pathogenic |
— |
| RS2516887030 |
IFNAR1
|
Health Risk |
Likely pathogenic |
Immunodeficiency 106, susceptibility to viral infections |
| RS2516902294 |
GNAS
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2516902375 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2516962940 |
IFNGR2
|
Health Risk |
Likely risk allele |
Susceptibility to severe COVID-19, Susceptibility to severe COVID-19 |
| RS2516964679 |
SIK1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 30 |
| RS2516965790 |
SIK1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 30 |
| RS2516966428 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS2516973680 |
GNAS
|
Health Risk |
Likely pathogenic |
McCune-Albright syndrome, McCune-Albright syndrome |
| RS2516986131 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2516988200 |
COL6A2
|
Health Risk |
Likely pathogenic |
— |
| RS2516989781 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2516992827 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2516992917 |
COL6A2
|
Health Risk |
Pathogenic |
BETHLEM MYOPATHY 1B, AUTOSOMAL RECESSIVE |
| RS2516992989 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2516994367 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2516994656 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2516995291 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2516996260 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2516996853 |
COL6A2
|
Health Risk |
Likely pathogenic |
— |
| RS2516996865 |
ERG
|
Health Risk |
Pathogenic |
Lymphatic malformation 14, Lymphatic malformation 14 |
| RS2516997121 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2516997223 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2516997347 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2516997727 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2516997767 |
RTEL1
|
Health Risk |
Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2516998156 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2516999509 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2516999821 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
COL6A2-related disorder, Bethlem myopathy 1A |
| RS2517002190 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2517003272 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2517005048 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1B, Bethlem myopathy 1B |
| RS2517005999 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2517006827 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2517006899 |
COL6A2
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 1B, Ullrich congenital muscular dystrophy 1B |
| RS2517009429 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2517009442 |
COL6A2
|
Health Risk |
Pathogenic |
— |